Latest Articlesddd
Vera Therapeutics As expected, Vera Therapeutics (VERA) product Ataticept achieved proteinuria reduction in ORIGIN Phase 3 …
Akero Therapeutics Akero Therapeutics (AKRO) - a clinical-stage company developing transformational treatments for patients with serious …
Vera Therapeutics Q: What did Vera Therapeutics announce on May 6th that is more than what …
Exelixis in the NEWS Two days ago, Exelixis (EXEL) reported financial results for the first quarter …
Yesterday's Market and CytomX Therapeutics May 12, 2025 was an excellent day for many stressed countries. …
PTC Therapeutics On May 6, 2025, PTC Therapeutics (PTCT) announced a corporate update and financial results …
Alnylam Pharmaceuticals Synopsis Today, May 1, 2025 - Alnylam Pharmaceuticals (ALNY), the leading RNAi therapeutics company …
Important News from AbbVie AbbVie (ABBV) submitted a biological license application (BLA) to the United States’ …
We still believe in many outperforming biotechnology firms whose stocks are underestimated on Wall Street. We …
Halozyme Therapeutics Q & A Yesterday, Halozyme Therapeutics (HALO) announced that Argenx Company (ARGX) has received …
Today's Stock Market Rally Today, Wednesday, April 9, 2025 the news started with Trump announcing a …
Rhythm Pharmaceuticals Rally Last week, almost all the stocks tumbled. On Monday, the first day of …
Novo Nordisk in the NEWS Novo Nordisk (NVO) presented the full results from STRIDE, a phase …
Stock Market Plummet and Alnylam Pharmaceuticals Good News Today, the stock market is plummeting. In fact, …
Wave Life Sciences On March 26, 2025, Wave Life Sciences (WVE) announced positive data from the …
BridgeBio Pharma Today, March 24, 2025, BridgeBio Pharma, Inc. (BBIO) announced that cardiovascular outcomes data in patients …
PTC Therapeutics Inc On March 20, 2025, PTC Therapeutics, Inc. (PTCT) shared new data from the Phase 3 APHENITY …
Alnylam Pharmaceuticals in the NEWS March 20, 2025, Alnylam Pharmaceuticals (ALNY) - the leading RNAi therapeutics company, …
Pyxis Oncology in the NEWS Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results …
Altimmune Altimmune (ALT) stock soared last Friday after speculation of a takeover by three large companies. …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
